1. Home
  2. MNPR vs FAT Comparison

MNPR vs FAT Comparison

Compare MNPR & FAT Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.

  • Machine Learning Prediction
  • ML Decision
  • MNPR
  • FAT
  • Stock Information
  • Founded
  • MNPR 2014
  • FAT 2017
  • Country
  • MNPR United States
  • FAT United States
  • Employees
  • MNPR N/A
  • FAT N/A
  • Industry
  • MNPR Biotechnology: Pharmaceutical Preparations
  • FAT Restaurants
  • Sector
  • MNPR Health Care
  • FAT Consumer Discretionary
  • Exchange
  • MNPR Nasdaq
  • FAT Nasdaq
  • Market Cap
  • MNPR 95.5M
  • FAT 94.4M
  • IPO Year
  • MNPR 2019
  • FAT 2017
  • Fundamental
  • Price
  • MNPR $18.09
  • FAT $5.28
  • Analyst Decision
  • MNPR Strong Buy
  • FAT
  • Analyst Count
  • MNPR 3
  • FAT 0
  • Target Price
  • MNPR $27.33
  • FAT N/A
  • AVG Volume (30 Days)
  • MNPR 1.5M
  • FAT 20.5K
  • Earning Date
  • MNPR 11-08-2024
  • FAT 10-30-2024
  • Dividend Yield
  • MNPR N/A
  • FAT 10.59%
  • EPS Growth
  • MNPR N/A
  • FAT N/A
  • EPS
  • MNPR N/A
  • FAT N/A
  • Revenue
  • MNPR N/A
  • FAT $606,008,000.00
  • Revenue This Year
  • MNPR N/A
  • FAT $34.73
  • Revenue Next Year
  • MNPR N/A
  • FAT $2.67
  • P/E Ratio
  • MNPR N/A
  • FAT N/A
  • Revenue Growth
  • MNPR N/A
  • FAT 42.38
  • 52 Week Low
  • MNPR $1.37
  • FAT $4.51
  • 52 Week High
  • MNPR $38.50
  • FAT $9.48
  • Technical
  • Relative Strength Index (RSI)
  • MNPR 60.19
  • FAT 49.33
  • Support Level
  • MNPR $16.26
  • FAT $5.22
  • Resistance Level
  • MNPR $19.70
  • FAT $5.75
  • Average True Range (ATR)
  • MNPR 2.15
  • FAT 0.26
  • MACD
  • MNPR -0.07
  • FAT -0.01
  • Stochastic Oscillator
  • MNPR 74.36
  • FAT 35.62

About MNPR Monopar Therapeutics Inc.

Monopar Therapeutics Inc is a clinical-stage biopharmaceutical company focused on developing proprietary therapeutics designed to extend life or improve the quality of life for cancer patients. The company's pipeline consists of Validive for the prevention of chemoradiotherapy-induced severe oral mucositis in oropharyngeal cancer patients, camsirubicin for the treatment of soft tissue sarcoma, a late-stage preclinical antibody, MNPR-101, for cancers and severe COVID-19 and an early-stage camsirubicin analog, MNPR-202, for various cancers.

About FAT FAT Brands Inc.

FAT Brands Inc is a multi-brand restaurant franchising company. It develops, markets, acquires and manages quick service, fast casual, casual dining, and polished casual dining restaurant concepts around the world. The company operates as a franchisor of restaurants, where the company generally does not own or operate the restaurant locations but rather generates revenue by charging franchisees an initial franchise fee as well as ongoing royalties. For some of the company's brands, it also directly owns and operates restaurant locations. Its brands include Round Table Pizza, Fatburger, Johnny Rockets, Twin Peaks, and Elevation Burger among others. Geographically, the majority of the revenue for the company is generated from the United States and the rest from other countries.

Share on Social Networks: